The antibody producing B-lymphocytes are generated throughout the life of most mammals and are essential for immune function. The functional B-lymphocytes are generated via differentiation of precursor B cells, which requires signaling via the B cell receptor (BCR) both during antigen independent and antigen dependent phases of development. Each step of differentiation is also characterized by epigenetic changes and expression patterns of a specific set of genes. However, the mechanism by which BCR signaling is connected to epigenetic changes in downstream target genes and alterations in their transcription during B cell activation is unknown. The multifunctional transcription factor TFII-I is activated upon BCR signaling and undergoes regulated translocation from the cytoplasm to the nucleus. TFII-I also interacts with various chromatin factors and regulates target genes including the immunoglobulin heavy chain, IgH. We hypothesize that by virtue of association with both general chromatin factors and cell type specific transcription factors in response to BCR-signaling, TFII-I connects BCR signaling to chromatin architecture and transcription of Ig and non-Ig genes. In addition, TFII-I intersects with the NF-B pathway. We propose that these interactions are functionally important for B cell proliferation. Because deregulation in signaling or gene expression in B cells can lead to various malignancies and immune deficiencies, it is our long-term goal to dissect in molecular detail the TFII-I mediated pathways operating in B cells. To investigate the BCR-mediated transcriptional and proliferative mechanisms in B cells, we propose the following specific aims: 1) To ascertain how TFII-I mediates BCR signaling via Btk and activates target genes; 2) To determine the role of TFII-I in IgH transcriptional regulation; 3) To elucidate the mechanism by which TFII-I intersects with the NF-B pathway

Public Health Relevance

The generation of differentiated cell types, from their corresponding undifferentiated precursors, is regulated by signals emerging from the cell extrinsic environment and the ability of the recipient cell to transduce these signals to effect changes in their gene expression patterns. Despite years of study, significant questions remain unanswered about how specific signals control genes responsible for immune function. TFII-I is a transcription factor that controls expression of the immunoglobulin gene in antibody producing B cells. We propose to study how this factor integrates external signals to control antibody production and thus, modulate immune function.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
High Priority, Short Term Project Award (R56)
Project #
1R56AI079206-01A2
Application #
8084528
Study Section
Cellular and Molecular Immunology - A Study Section (CMIA)
Program Officer
Ferguson, Stacy E
Project Start
2010-06-15
Project End
2012-05-31
Budget Start
2010-06-15
Budget End
2012-05-31
Support Year
1
Fiscal Year
2010
Total Cost
$396,250
Indirect Cost
Name
Tufts University
Department
Pathology
Type
Schools of Medicine
DUNS #
039318308
City
Boston
State
MA
Country
United States
Zip Code
02111
Fowler, Trent; Suh, Hyunsuk; Buratowski, Stephen et al. (2013) Regulation of primary response genes in B cells. J Biol Chem 288:14906-16
Roy, Ananda L (2012) Biochemistry and biology of the inducible multifunctional transcription factor TFII-I: 10 years later. Gene 492:32-41
Roy, Ananda L; Sen, Ranjan; Roeder, Robert G (2011) Enhancer-promoter communication and transcriptional regulation of Igh. Trends Immunol 32:532-9
Fowler, Trent; Sen, Ranjan; Roy, Ananda L (2011) Regulation of primary response genes. Mol Cell 44:348-60